Operational Resilience Manager
Pubblicato il 17-08-2026 - Biotecnologie - Farmacia - Chimica in Parma
Select how often (in days) to receive an alert:Department: Corporate Operations Strategy & OptimizationJob Type: Direct EmployeeTeam: Industrial Operations & HSEContract Type: PermanentLocation: Parma, ITAbout usBased in Parma, Italy, Chiesi is an international research-focused pharmaceutical and healthcare group with over 85 years' experience, operating in 31 countries with more than 7,000 employees (Chiesi Group). To achieve its mission of improving people's quality of life by acting responsibly towards society and the environment, the Group researches, develops and markets innovative drugs in its main therapeutic areas: We are proud to have been awarded with B Corp Certification, a recognition of high social and environmental standards. Our people make a critical difference to our success, which is why it is vital that we attract and retain the right talent who will continue to enrich our culture by living and breathing our values and behaviors.In fact, we are a global family made up of different cultures, different genders, generations, ethnicities, abilities,
sexual identities and many other enriching diversities.Chiesi Global Manufacturing DivisionChiesi Group has three production plants: The plants produce a total of over 110 million units per year.The production plant in Parma covers a total area of more than fifteen thousand square meters and it is the strategic hub for the production and distribution of our products, being an international supply center that exports to more than 80 countries. The Parma plant produces solid medicinal products, such as tablets and inhaled dry powders; vials of sterile suspension for endotracheal administration; Santana produces pressurized solutions and suspensions for inhalant therapy (MDIs) and supplies both domestic market and Group's Affiliates and exports to licensees and distributors. Blois specializes in Dry Powder Inhalers and final assembly stages of the Metered-Dose Inhalers (MDIs), supplies Group's Affiliates and